Avricore Health Inc. (TSXV:AVCR)
0.0550
0.00 (0.00%)
Apr 23, 2025, 12:23 PM EDT
Avricore Health Cash Flow Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
Net Income | 0.1 | -0.7 | -0.82 | -1.71 | -1.17 | -2.11 | Upgrade
|
Depreciation & Amortization | 0.45 | 0.41 | 0.18 | 0.02 | - | 0.19 | Upgrade
|
Other Amortization | 0.02 | 0.01 | 0.01 | - | - | - | Upgrade
|
Asset Writedown & Restructuring Costs | - | - | - | - | - | 0.31 | Upgrade
|
Stock-Based Compensation | 0.51 | 0.7 | 0.33 | 0.5 | 0.13 | 0.09 | Upgrade
|
Provision & Write-off of Bad Debts | 0 | 0 | 0.01 | - | - | - | Upgrade
|
Other Operating Activities | -0.01 | - | - | 0.04 | 0.29 | 0.19 | Upgrade
|
Change in Accounts Receivable | -0.12 | 0.34 | -0.69 | -0.08 | 0 | - | Upgrade
|
Change in Inventory | - | -0.02 | - | - | -0.18 | - | Upgrade
|
Change in Accounts Payable | -0.07 | 0.18 | 0.27 | -0.07 | -0.34 | 0.36 | Upgrade
|
Change in Unearned Revenue | - | -0.25 | 0.25 | - | - | - | Upgrade
|
Change in Other Net Operating Assets | 0.02 | -0.01 | 0.02 | 0.07 | 0.05 | 0.11 | Upgrade
|
Operating Cash Flow | 0.91 | 0.66 | -0.44 | -1.23 | -1.22 | -0.69 | Upgrade
|
Capital Expenditures | -0.52 | -1.02 | -1.19 | -0.11 | - | - | Upgrade
|
Sale (Purchase) of Intangibles | -0.03 | -0.03 | -0.01 | -0.04 | - | - | Upgrade
|
Investment in Securities | - | - | -0.01 | - | - | - | Upgrade
|
Investing Cash Flow | -0.55 | -1.05 | -1.21 | -0.14 | - | - | Upgrade
|
Short-Term Debt Issued | - | - | - | - | 0.94 | - | Upgrade
|
Total Debt Issued | - | - | - | - | 0.94 | - | Upgrade
|
Short-Term Debt Repaid | - | - | - | -1 | - | - | Upgrade
|
Long-Term Debt Repaid | - | - | - | - | -0.01 | -0.05 | Upgrade
|
Total Debt Repaid | -0.03 | - | - | -1 | -0.01 | -0.05 | Upgrade
|
Net Debt Issued (Repaid) | -0.03 | - | - | -1 | 0.93 | -0.05 | Upgrade
|
Issuance of Common Stock | 0.07 | 0.04 | 0.25 | 4.18 | 0.64 | 0.5 | Upgrade
|
Other Financing Activities | - | - | - | -0.1 | -0.06 | 0.17 | Upgrade
|
Financing Cash Flow | 0.04 | 0.04 | 0.25 | 3.08 | 1.51 | 0.62 | Upgrade
|
Net Cash Flow | 0.39 | -0.34 | -1.39 | 1.71 | 0.29 | -0.07 | Upgrade
|
Free Cash Flow | 0.39 | -0.36 | -1.63 | -1.34 | -1.22 | -0.69 | Upgrade
|
Free Cash Flow Margin | 8.20% | -10.36% | -92.24% | -1090.74% | -3703.89% | -2080.02% | Upgrade
|
Free Cash Flow Per Share | 0.00 | -0.00 | -0.02 | -0.01 | -0.02 | -0.01 | Upgrade
|
Levered Free Cash Flow | 0.37 | -0.05 | -1.23 | -0.65 | -1.06 | 0.08 | Upgrade
|
Unlevered Free Cash Flow | 0.37 | -0.05 | -1.23 | -0.63 | -0.97 | 0.08 | Upgrade
|
Change in Net Working Capital | 0.17 | -0.24 | 0.13 | 0.12 | 0.44 | -0.81 | Upgrade
|
Updated Nov 29, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.